Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

The Beachbody Company, Inc. Announces First Quarter 2023 Earnings Release Date, Conference Call and Webcast


The Beachbody Company, Inc. (NYSE: BODY) ("Beachbody" or the "Company"), a leading subscription health and wellness company, will release its first quarter 2023 results on Monday, May 8, 2023, after the U.S. stock market closes. The Company will host a conference call at 5:00 p.m. (Eastern Time) that day to discuss the results.

The toll-free dial-in for the conference call is (833) 470 1428 (U.S. & Canada), or +1 404 975 4839 (all other locations). The conference ID is 878296. A live webcast of the conference call will also be available on the Company's investor relations website at https://investors.thebeachbodycompany.com/.

For those unable to participate in the conference call, a replay will be available after the conclusion of the call on May 8, 2023 through May 15, 2023. The toll-free replay dial-in number is (866) 813-9403 (U.S. & Canada), or +1 929 458 6194 (all other locations). The replay passcode is 649427.

About BODi and The Beachbody Company, Inc.
Headquartered in Southern California, BODi is a leading digital fitness, nutrition, and mindset subscription company with over two decades of creating innovative content and nutritional supplements designed to support and enrich strong Health Esteem. The Beachbody Company, Inc. is the parent company of BODi. For more information, please visit TheBeachbodyCompany.com.


These press releases may also interest you

at 06:35
Apogee Enterprises, Inc. will report its fiscal 2024 fourth quarter and full-year results on Thursday, April 18, 2024, before the market opens. The company will also host a conference call to discuss its financial results. This conference call will...

at 06:35
Metals Acquisition Limited ARBN 671 963 198 , a private limited company incorporated under the laws of Jersey, Channel Islands ("MAC" or the "Company") announces its Annual Report for the financial year ended 31 December 2023 ("2023 Annual Report")....

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Verde AgriTech Ltd ("Verde" or the "Company") announces its financial results for the full year ended December 31, 2023 ("FY 2023") and the fourth quarter 2023 ("Q4 2023"), as audited by Ernst & Young ("EY"). The FY 2023 audited results were...

at 06:30
Hut 8 Corp. ("Hut 8" or the "Company"), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America's largest Bitcoin miners, today announced its financial results for the six months ended...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...



News published on and distributed by: